| Oct 2 |
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
|
| Oct 2 |
Is It Time to Buy September's Worst-Performing S&P 500 Stocks?
|
| Oct 1 |
The Covid Era Tech Promises To Reinvent Cancer Treatment
|
| Oct 1 |
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
|
| Oct 1 |
Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?
|
| Oct 1 |
MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine
|
| Oct 1 |
Company News for Oct 1, 2024
|
| Oct 1 |
IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
|
| Oct 1 |
Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US
|
| Oct 1 |
Moderna, Cenra Healthcare enter JV to promote mRNA respiratory vaccine in Taiwan
|
